As of 3:59pm ET
| +0.03 / +0.23%|
The 6 analysts offering 12-month price forecasts for Cross Country Healthcare Inc have a median target of 17.50, with a high estimate of 21.00 and a low estimate of 15.00. The median estimate represents a +31.28% increase from the last price of 13.33.
The current consensus among 7 polled investment analysts is to Buy stock in Cross Country Healthcare Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.